Roche's SERD Setback Means Menarini Retains An Edge

 
• By Jessica Merrill
  
horse race
Roche's SERD failed a Phase II trial in advanced breast cancer • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category